Pharm Exec's latest annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.

Fosun International Ltd.’s health-care business and Shanghai Pharmaceuticals Holding Co. are among bidders for a stake in U.S. specialty drugmaker Arbor Pharmaceuticals LLC, according to people with knowledge of the matter.

New, Non-Invasive Method May Help with Diagnosis

More than one-third (35.6 percent) of surveyed professionals in the Internet of Things-connected medical device ecosystem say their organizations have experienced a cybersecurity incident in the past year, according to a recent Deloitte poll. Identifying and mitigating the risks of fielded and legacy connected devices presents the industry’s biggest cybersecurity challenge according to respondents (30.1 percent).